Articles by Erika Meler, DVM, MS

Research Updates: Ascites validated as a powerful prognostic indicator in canine chronic hepatitis

Feb 1, 2010
By: Erika Meler, DVM, MS, Barrak Pressler, DVM, PhD, DACVIM

This study confirms that in dogs with confirmed primary chronic hepatitis, those patients with ascites at the time of diagnosis will have significantly decreased survival times compared with those without ascites.

Research Updates: Single-injection antibiotic treatment for cats with abscesses and infected wounds

Oct 1, 2009
By: Erika Meler, DVM, MS, Barrak Pressler, DVM, PhD, DACVIM

Cephalosporins are often used as first-line antibiotics for superficial skin infections in dogs and cats.

Research Updates: Investigating the impact of vaccine administration site changes in cats

Oct 1, 2009
By: Erika Meler, DVM, MS, Barrak Pressler, DVM, PhD, DACVIM

Of the currently marketed feline vaccines, those against rabies and feline leukemia virus (FeLV) have been most commonly implicated in sarcoma development.

Research Updates: Antigen and antibody tests for diagnosing and monitoring blastomycosis in dogs

May 1, 2009
By: Erika Meler, DVM, MS, Barrak Pressler, DVM, PhD, DACVIM

The study discussed here demonstrates that enzyme immunoassay detection of B. dermatitidis antigen is a valuable addition to the arsenal of diagnostic tests.

The effect of phenobarbital on serum triglyceride concentrations in epileptic dogs

May 1, 2009
By: Erika Meler, DVM, MS, Barrak Pressler, DVM, PhD, DACVIM

This study demonstrates that epileptic dogs treated with phenobarbital alone or in combination with potassium bromide are more likely to be hypertriglyceridemic.

The most prevalent diseases and major causes of death in retired racing greyhounds

May 1, 2009
By: Erika Meler, DVM, MS, Barrak Pressler, DVM, PhD, DACVIM

Retired racing greyhounds have become increasingly popular pets, but only sparse information regarding disease prevalence in this subset of dogs has been reported.

« Previous